Literature DB >> 2612907

The cell-specific transcription factor PTF1 contains two different subunits that interact with the DNA.

E Roux1, M Strubin, O Hagenbüchle, P K Wellauer.   

Abstract

The cognate sequence of transcription factor PTF1, which plays a key role in pancreas-specific gene expression, has a bipartite organization. Two separate DNA domains, the A and the B boxes, are required for efficient binding of the factor. The structure of PTF1 was elucidated by cross-linking purified PTF1 to DNA templates that had been differentially substituted with azido-deoxyuridine (N3.dU). This site-directed UV cross-linking shows that PTF1 contains two DNA-binding proteins, distinct in size and sensitivity to Staphylococcus aureus V8 protease. A 64-kD protein is cross-linked with DNA containing N3.dU substitutions in the A box, and a 48-kD protein is cross-linked with DNA containing N3.dU substitutions in the B box. Both proteins bind simultaneously to the same DNA molecule. The data indicate that PTF1 is a heteromeric oligomer and that its cell-specific DNA-binding potential is the result of a concerted activity of two DNA-binding subunits.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612907     DOI: 10.1101/gad.3.10.1613

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  29 in total

1.  RNA profiling and chromatin immunoprecipitation-sequencing reveal that PTF1a stabilizes pancreas progenitor identity via the control of MNX1/HLXB9 and a network of other transcription factors.

Authors:  Nancy Thompson; Emilie Gésina; Peter Scheinert; Philipp Bucher; Anne Grapin-Botton
Journal:  Mol Cell Biol       Date:  2012-01-09       Impact factor: 4.272

2.  A rapid method for the isolation of DNA-binding proteins from purified nuclei of tissues and cells in culture.

Authors:  O Hagenbüchle; P K Wellauer
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

3.  Exocrine pancreas transcription factor 1 binds to a bipartite enhancer element and activates transcription of acinar genes.

Authors:  S L Weinrich; A Meister; W J Rutter
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  Transactivation of pancreas-specific gene sequences in somatic cell hybrids.

Authors:  K J Wu; L C Samuelson; G Howard; M H Meisler; G J Darlington
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  The bHLH domain of Mistl is sufficient to activate gene transcription.

Authors:  Thai Tran; Di Jia; Yan Sun; Stephen F Konieczny
Journal:  Gene Expr       Date:  2007

6.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

7.  A nonclassical bHLH Rbpj transcription factor complex is required for specification of GABAergic neurons independent of Notch signaling.

Authors:  Kei Hori; Justyna Cholewa-Waclaw; Yuji Nakada; Stacey M Glasgow; Toshihiko Masui; R Michael Henke; Hendrik Wildner; Benedetta Martarelli; Thomas M Beres; Jonathan A Epstein; Mark A Magnuson; Raymond J Macdonald; Carmen Birchmeier; Jane E Johnson
Journal:  Genes Dev       Date:  2008-01-15       Impact factor: 11.361

Review 8.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

9.  The DNA-binding activity of transcription factor PTF1 parallels the synthesis of pancreas-specific mRNAs during mouse development.

Authors:  S Petrucco; P K Wellauer; O Hagenbüchle
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

10.  The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesis.

Authors:  Michael A Hale; Galvin H Swift; Chinh Q Hoang; Tye G Deering; Toshi Masui; Youn-Kyoung Lee; Jumin Xue; Raymond J MacDonald
Journal:  Development       Date:  2014-07-25       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.